7XY Stock Overview
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in Sweden, the United Kingdom, Rest of Europe, North America, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Swedencare AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 4.04 |
| 52 Week High | SEK 5.96 |
| 52 Week Low | SEK 3.41 |
| Beta | 0.86 |
| 1 Month Change | 5.43% |
| 3 Month Change | 2.18% |
| 1 Year Change | -24.76% |
| 3 Year Change | -71.09% |
| 5 Year Change | n/a |
| Change since IPO | -62.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7XY | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -7.3% | -3.9% | -2.6% |
| 1Y | -24.8% | -15.2% | 7.1% |
Return vs Industry: 7XY underperformed the German Pharmaceuticals industry which returned -13.7% over the past year.
Return vs Market: 7XY underperformed the German Market which returned 8% over the past year.
Price Volatility
| 7XY volatility | |
|---|---|
| 7XY Average Weekly Movement | 5.8% |
| Pharmaceuticals Industry Average Movement | 5.4% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.6% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 7XY has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 7XY's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 570 | Hakan Lagerberg | www.swedencare.com |
Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in Sweden, the United Kingdom, Rest of Europe, North America, Asia, and internationally. The company offers animal nutritional supplements, treats, and grooming products under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, urology, nephrology, and ophthalmology under the Innovet name; and support and solutions for the veterinary community under the Stratford Animal Health name. It also provides pet health supplements under the NaturVet, VETCLASSICS, and NutriScience name; pet supplements, vitamins, dental care, ear cleaners, pilling agents, and topicals under the Pet MD name; and vet-formulated pet care products under the VetWELL name.
Swedencare AB (publ) Fundamentals Summary
| 7XY fundamental statistics | |
|---|---|
| Market cap | €665.81m |
| Earnings (TTM) | €5.40m |
| Revenue (TTM) | €217.66m |
123.4x
P/E Ratio3.1x
P/S RatioIs 7XY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7XY income statement (TTM) | |
|---|---|
| Revenue | SEK 2.50b |
| Cost of Revenue | SEK 1.06b |
| Gross Profit | SEK 1.45b |
| Other Expenses | SEK 1.39b |
| Earnings | SEK 62.10m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 13, 2025
| Earnings per share (EPS) | 0.39 |
| Gross Margin | 57.86% |
| Net Profit Margin | 2.48% |
| Debt/Equity Ratio | 18.0% |
How did 7XY perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield59%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 23:47 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Swedencare AB (publ) is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Johan Brown | ABG Sundal Collier Sponsored |
| Martin Comtesse | Jefferies LLC |
| Adrian Elmlund | Nordea Markets |